Search results
Pfizer’s Phase III DMD gene therapy trial misses primary endpoint
Clinical Trials Arena via Yahoo Finance· 4 days agoPfizer has reported that its Phase III CIFFREO clinical trial of investigational mini-dystrophin ...
Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
Zacks via Yahoo Finance· 3 days agoPfizer's (PFE) phase III study, CIFFREO, fails to show improvement in motor function in ambulatory...
No commercial incentive to develop gene therapy – hospitals will try to fill the gap - EconoTimes
EconoTimes· 4 days agoIndividually, rare diseases are rare, but there are so many rare diseases that over 400 million...
What New Gene Therapy Means For Sickle Cell Patients
Forbes· 2 days agoRecently, a 12-year-old boy became the first patient with sickle cell disease to begin commercially approved gene therapy that could potentially cure the...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 6 days agoCell & Gene Therapy Supply Chain Software Market Expected to Grow at a 13.9% CAGR from 2024-2031 | Latest Report by InsightAce Analytic PR Newswire JERSEY ...
Pfizer's Duchenne gene therapy fails in late-stage study
Reuters· 4 days ago, opens new tab said on Wednesday its experimental gene therapy for Duchenne muscular dystrophy...
Pfizer's Duchenne gene therapy fails in late-stage study
Reuters via Yahoo News· 4 days agoThe therapy also did not show a significant difference compared to placebo in secondary goals of the...
Sarepta Jumps After Rival Gene Therapy From Pfizer Flops
Investor's Business Daily· 3 days agoThe news gives Sarepta Therapeutics (SRPT) an edge heading to June 21, when the Food and Drug Administration will decide whether to fully approve Elevidys for patients with the muscle-wasting ...
Pfizer's gene-therapy trial failure boosts Sarepta's stock
Morningstar· 3 days agoShares of Sarepta Therapeutics Inc. (SRPT) gained 4% premarket on Thursday after a potential competitor to its gene therapy stumbled in a late-stage trial ...
Breaking News, Business, Financial and Economic News, World News from EconoTimes
EconoTimes· 4 days agoClaire is Professor of paediatric immunology and gene therapy at UCL Great Ormond Street Hospital...
